Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers

Alzheimer’s disease (AD) is the most prevalent dementia, but it shows similar initial symptoms to other neurocognitive diseases (Lewy body disease (LBD) and frontotemporal dementia (FTD)). Thus, the identification of reliable AD plasma biomarkers is required. The aim of this work is to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez-Sánchez, Lourdes, Peña-Bautista, Carmen, Ferré-González, Laura, Cubas, Laura, Balaguer, Angel, Casanova-Estruch, Bonaventura, Baquero, Miguel, Cháfer-Pericás, Consuelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532221/
https://www.ncbi.nlm.nih.gov/pubmed/37762457
http://dx.doi.org/10.3390/ijms241814151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532221/
https://www.ncbi.nlm.nih.gov/pubmed/37762457
http://dx.doi.org/10.3390/ijms241814151

Ejemplares similares